Lead Generation and Optimization Based on Protein-Ligand Complementarity

被引:9
作者
Ogata, Koji [1 ]
Isomura, Tetsu [2 ]
Kawata, Shinji [3 ]
Yamashita, Hiroshi [3 ]
Kubodera, Hideo [3 ]
Wodak, Shoshana J. [1 ,4 ,5 ]
机构
[1] Hosp Sick Children, Ctr Computat Biol, Toronto, ON M5G 1X8, Canada
[2] Mitsubishi Tanabe Pharma Corp, Adv Med Res Labs, Aoba Ku, Kanagawa 2270033, Japan
[3] Mitsubishi Tanabe Pharma Corp, Med Chem Res Labs, Aoba Ku, Kanagawa 2270033, Japan
[4] Univ Toronto, Dept Biochem, Toronto, ON, Canada
[5] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada
关键词
lock-and-key problem; computational structure-based drug design; lead generation; lead optimization; DE-NOVO DESIGN; COMBINATORIAL LIBRARIES; INHIBITORS; SIMILARITY; KINASE; DOCKING; IDENTIFICATION; HETEROCYCLES; SEARCH; SYSTEM;
D O I
10.3390/molecules15064382
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
This work proposes a computational procedure for structure-based lead generation and optimization, which relies on the complementarity of the protein-ligand interactions. This procedure takes as input the known structure of a protein-ligand complex. Retaining the positions of the ligand heavy atoms in the protein binding site it designs structurally similar compounds considering all possible combinations of atomic species (N, C, O, CH3, NH, etc). Compounds are ranked based on a score which incorporates energetic contributions evaluated using molecular mechanics force fields. This procedure was used to design new inhibitor molecules for three serine/threonine protein kinases (p38 MAP kinase, p42 MAP kinase (ERK2), and c-Jun N-terminal kinase 3 (JNK3)). For each enzyme, the calculations produce a set of potential inhibitors whose scores are in agreement with IC50 data and Ki values. Furthermore, the native ligands for each protein target, scored within the five top-ranking compounds predicted by our method, one of the top-ranking compounds predicted to inhibit JNK3 was synthesized and his inhibitory activity confirmed against ATP hydrolysis. Our computational procedure is therefore deemed to be a useful tool for generating chemically diverse molecules active against known target proteins.
引用
收藏
页码:4382 / 4400
页数:19
相关论文
共 46 条
[21]   RUSTING OF THE LOCK AND KEY MODEL FOR PROTEIN-LIGAND BINDING [J].
JORGENSEN, WL .
SCIENCE, 1991, 254 (5034) :954-955
[22]   Strategies to design pyrazolyl urea derivatives for p38 kinase inhibition: a molecular modeling study [J].
Kulkarni, Ravindra G. ;
Srivani, Palukuri ;
Achaiah, Garlapati ;
Sastry, G. Narahari .
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2007, 21 (04) :155-166
[23]   Drug-like properties and the causes of poor solubility and poor permeability [J].
Lipinski, CA .
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2000, 44 (01) :235-249
[24]   Scaffold hopping in de novo design. Ligand generation in the absence of receptor information [J].
Lloyd, DG ;
Buenemann, CL ;
Todorov, NP ;
Manallack, DT ;
Dean, PM .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (03) :493-496
[26]   New 4-point pharmacophore method for molecular similarity and diversity applications: Overview of the method and applications, including a novel approach to the design of combinatorial libraries containing privileged substructures [J].
Mason, JS ;
Morize, I ;
Menard, PR ;
Cheney, DL ;
Hulme, C ;
Labaudiniere, RF .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (17) :3251-3264
[27]   ORIENTATIONAL SAMPLING AND RIGID-BODY MINIMIZATION IN MOLECULAR DOCKING [J].
MENG, EC ;
GSCHWEND, DA ;
BLANEY, JM ;
KUNTZ, ID .
PROTEINS-STRUCTURE FUNCTION AND GENETICS, 1993, 17 (03) :266-278
[28]   Fingerprint directed scaffold hopping for identification of CCR2 antagonists [J].
Nair, Pramod C. ;
Sobhia, M. Elizabeth .
JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2008, 48 (09) :1891-1902
[29]   CONFIRMATION OF USEFULNESS OF A STRUCTURE CONSTRUCTION PROGRAM BASED ON 3-DIMENSIONAL RECEPTOR STRUCTURE FOR RATIONAL LEAD GENERATION [J].
NISHIBATA, Y ;
ITAI, A .
JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (20) :2921-2928
[30]   Scaffold hopping and optimization towards libraries of glycogen synthase kinase-3 inhibitors [J].
Nærum, L ;
Norskov-Lauritsen, L ;
Olesen, PH .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (11) :1525-1528